用于心房颤动中风风险分层的CHADS2评分——是友还是敌？ - Suppr

The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?

作者信息

Karthikeyan G, Eikelboom J W

机构信息

All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

出版信息

Thromb Haemost. 2010 Jul;104(1):45-8. doi: 10.1160/TH09-11-0757. Epub 2010 May 10.

DOI:10.1160/TH09-11-0757

PMID:20458437

Abstract

摘要

相似文献

The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?

Thromb Haemost. 2010 Jul;104(1):45-8. doi: 10.1160/TH09-11-0757. Epub 2010 May 10.

Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.

Age Ageing. 2004 Nov;33(6):544-7. doi: 10.1093/ageing/afh211.

Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.

Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.

Anticoagulation in the octogenarian with atrial fibrillation.

Med Health R I. 2009 Apr;92(4):152-4.

Stroke in heart failure: atrial fibrillation revisited?

J Stroke Cerebrovasc Dis. 2010 Jan;19(1):1-2. doi: 10.1016/j.jstrokecerebrovasdis.2009.09.002.

Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.

Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.

Bleeding risk on warfarin among elderly patients with atrial fibrillation.

J Am Coll Cardiol. 2010 Mar 2;55(9):932; author reply 932-3. doi: 10.1016/j.jacc.2009.11.037.

Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.

Thromb Res. 2007;121(3):347-52. doi: 10.1016/j.thromres.2007.05.014. Epub 2007 Jun 26.

Identifying AF patients at risk of stroke: can prothrombotic indices improve things?

Int J Cardiol. 2008 Jun 6;126(3):299-301. doi: 10.1016/j.ijcard.2007.08.092. Epub 2008 Feb 20.

Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program.

J Clin Pharm Ther. 2011 Feb;36(1):71-9. doi: 10.1111/j.1365-2710.2009.01156.x.

引用本文的文献

Does CHA2DS2-VASc score predict mortality in chronic kidney disease?

Intern Emerg Med. 2021 Oct;16(7):1737-1742. doi: 10.1007/s11739-021-02799-5. Epub 2021 Jul 7.

Analysis of risk factors for thrombosis of the left atrium/left atrial appendage in patients with non-valvular atrial fibrillation.

Cardiovasc J Afr. 2021;32(3):116-122. doi: 10.5830/CVJA-2019-071. Epub 2021 Apr 16.

Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.

Indian Heart J. 2021 Mar-Apr;73(2):244-248. doi: 10.1016/j.ihj.2021.02.003. Epub 2021 Feb 10.

Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting.

Ther Adv Drug Saf. 2018 Feb;9(2):97-111. doi: 10.1177/2042098617744926. Epub 2017 Dec 13.

Preventative Measures of Stroke in Patients With Atrial Fibrillation.

J Atr Fibrillation. 2012 Apr 14;4(6):399. doi: 10.4022/jafib.399. eCollection 2012 Apr-May.

Stroke Prevention in Atrial Fibrillation.

J Atr Fibrillation. 2010 Oct 22;3(3):279. doi: 10.4022/jafib.279. eCollection 2010 Oct-Nov.

Stroke And Bleeding Risk Assessment: Where Are We Now?

J Atr Fibrillation. 2014 Apr 30;6(6):1042. doi: 10.4022/jafib.1042. eCollection 2014 Apr-May.

The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants.

Indian Heart J. 2015 Dec;67 Suppl 2(Suppl 2):S13-34. doi: 10.1016/j.ihj.2015.10.380. Epub 2015 Nov 24.

Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation: A Meta-Analysis of Observational Studies.

Medicine (Baltimore). 2015 Dec;94(50):e2233. doi: 10.1097/MD.0000000000002233.

Hospital Admissions, Costs, and 30-Day Readmissions Among Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran Etexilate or Warfarin.

J Manag Care Spec Pharm. 2015 Nov;21(11):1039-53. doi: 10.18553/jmcp.2015.21.11.1039.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献